Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle.
作者信息
Mullen P, Scott W N, Miller W R
机构信息
I.C.R.F., Medical Oncology Unit, Western General Hospital, Edinburgh, UK.
出版信息
Br J Cancer. 1991 Jun;63(6):930-2. doi: 10.1038/bjc.1991.203.
Abstract
摘要
相似文献
1
Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle.向MCF-7乳腺癌细胞系的克隆变体施用促黄体生成素释放激素（LHRH）激动剂后观察到的生长抑制伴随着细胞在细胞周期的G0/G1期的积累。
Br J Cancer. 1991 Jun;63(6):930-2. doi: 10.1038/bjc.1991.203.
2
Interleukin-1 alpha differentially synchronizes estrogen-dependent and estrogen-independent human breast cancer cells in the G0/G1 phase of the cell cycle.
Anticancer Res. 1991 Jan-Feb;11(1):25-31.
3
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells.促黄体生成素释放激素激动剂对MCF-7人乳腺癌细胞的直接抑制作用。
Eur J Cancer Clin Oncol. 1985 Dec;21(12):1493-9. doi: 10.1016/0277-5379(85)90244-5.
4
Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.促黄体生成素释放激素激动剂和拮抗剂对MCF-7乳腺癌细胞的直接作用。
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2336-9. doi: 10.1073/pnas.89.6.2336.
5
G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).肌醇六磷酸（IP6）对人癌细胞系的G0/G1期阻滞和S期抑制作用
Anticancer Res. 2001 Jul-Aug;21(4A):2393-403.
6
Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.糖皮质激素可诱导Con8大鼠乳腺肿瘤细胞发生G1/G0期细胞周期阻滞，而撤去类固醇或添加转化生长因子-α可使其同步逆转。
Mol Endocrinol. 1993 Sep;7(9):1121-32. doi: 10.1210/mend.7.9.8247014.
7
Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis.特赫醇内酯通过诱导 G0/G1 期阻滞和细胞凋亡抑制 MCF-7 人乳腺癌细胞的增殖。
Free Radic Biol Med. 2012 May 1;52(9):1987-99. doi: 10.1016/j.freeradbiomed.2012.01.026. Epub 2012 Feb 4.
8
Hyaluronan arrests human breast cancer cell growth by prolonging the G0/G1 phase of the cell cycle.透明质酸通过延长细胞周期的 G0/G1 期来阻止人类乳腺癌细胞的生长。
Acta Biochim Biophys Sin (Shanghai). 2018 Dec 1;50(12):1181-1189. doi: 10.1093/abbs/gmy126.
9
Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.苯乙酸钠（NaPa）可诱导乳腺肿瘤上皮细胞的增殖、黏附及细胞周期发生改变。
Anticancer Res. 1999 May-Jun;19(3A):2121-6.
10
Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium.
J Clin Endocrinol Metab. 1991 May;72(5):1036-41. doi: 10.1210/jcem-72-5-1036.
引用本文的文献
1
Fertility preservation in reproductive-age women facing gonadotoxic treatments.面临性腺毒性治疗的育龄妇女的生育力保存
Curr Oncol. 2015 Aug;22(4):e294-304. doi: 10.3747/co.22.2334.
2
GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor.促性腺激素释放激素（1 - 5）通过一种孤儿G蛋白偶联受体在石川人子宫内膜细胞中反式激活表皮生长因子受体。
Mol Endocrinol. 2014 Jan;28(1):80-98. doi: 10.1210/me.2013-1203. Epub 2013 Jan 1.
3
Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues.促性腺激素释放激素（GnRH）类似物的结构修饰与偶联对其抗增殖活性的影响。
Cell Prolif. 2000 Oct;33(5):275-85. doi: 10.1046/j.1365-2184.2000.00180.x.
4
Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity.具有强选择性抗肿瘤活性的促性腺激素释放激素类似物缀合物。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2361-6. doi: 10.1073/pnas.96.5.2361.
5
Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.促黄体生成素释放激素（LH-RH）的细胞毒性类似物（T-98）对雌激素依赖性MXT小鼠乳腺癌生长的影响：肿瘤生长特征与表皮生长因子（EGF）受体含量之间的相关性
Breast Cancer Res Treat. 1996;40(2):129-39. doi: 10.1007/BF01806208.
6
Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters.人乳腺癌活检中促性腺激素释放激素激动剂（布舍瑞林）结合位点的特征及其与肿瘤参数相关的分布情况。
Breast Cancer Res Treat. 1993;25(1):37-46. doi: 10.1007/BF00662399.
7
Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.雌二醇、亮丙瑞林、他莫昔芬和醋酸甲羟孕酮对乳腺癌细胞生长及甾体激素受体的联合作用
J Cancer Res Clin Oncol. 1994;120(10):605-9. doi: 10.1007/BF01212815.
本文引用的文献
1
A new class of contraceptives?一类新型避孕药？
Nature. 1982 Apr 1;296(5856):391-2. doi: 10.1038/296391a0.
2
Long-term storage of samples for flow cytometric DNA analysis.用于流式细胞术DNA分析的样本长期保存。
Cytometry. 1983 Mar;3(5):317-22. doi: 10.1002/cyto.990030502.
3
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.在绝经前转移性乳腺癌中，使用或不使用他莫昔芬的情况下，长期使用促黄体生成素释放激素激动剂（布舍瑞林）的抗肿瘤和内分泌作用。
Breast Cancer Res Treat. 1984;4(3):209-20. doi: 10.1007/BF01806487.
4
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.一种用于制备细胞核以进行流式细胞术DNA分析的去污剂-胰蛋白酶法。
Cytometry. 1983 Mar;3(5):323-7. doi: 10.1002/cyto.990030503.
5
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells.促黄体生成素释放激素激动剂对MCF-7人乳腺癌细胞的直接抑制作用。
Eur J Cancer Clin Oncol. 1985 Dec;21(12):1493-9. doi: 10.1016/0277-5379(85)90244-5.
6
The treatment of postmenopausal women with advanced breast cancer with buserelin.
Cancer Chemother Pharmacol. 1985;15(2):171-3. doi: 10.1007/BF00257531.
7
Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7.人乳腺癌细胞系MCF-7一系列亚系的体外特性与致瘤性的关系。
Cancer Res. 1986 Dec;46(12 Pt 1):6339-48.
8
LHRH agonists and human breast cancer cells.
Nature. 1987;329(6142):770. doi: 10.1038/329770a0.
9
Clinical applications of LHRH analogues.促性腺激素释放激素类似物的临床应用。
Baillieres Clin Endocrinol Metab. 1987 Feb;1(1):43-70. doi: 10.1016/s0950-351x(87)80052-6.
10
Treatment of breast cancer with gonadotropin-releasing hormone.
Endocr Rev. 1986 Feb;7(1):89-94. doi: 10.1210/edrv-7-1-89.
Zotero 插件